LOCK-UP AGREEMENTLock-Up Agreement • February 20th, 2019 • Yarkoni Shai • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 20th, 2019 Company IndustryThis Lock-Up Agreement (this “Agreement”) is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) between Cellect Biotechnology Ltd., a company organized under the laws of the State of Israel (the “Company”), and A.G.P./Alliance Global Partners (“A.G.P.”), as representative of a group of underwriters (collectively, the “Underwriters”), to be named on Schedule I to the Underwriting Agreement, relating to the proposed public offering (the “Offering”) of: (i) (a) American Depositary Shares of the Company (the “ADSs”), each representing twenty ordinary shares, no par value per share, of the Company (the “Ordinary Shares”) and (b) pre-funded warrants to purchase ADSs at an exercise price of $0.01 per share; and (ii) warrants to purchase ADSs at an exercise price to be finalized prior to consummation of the Offering.
VOTING AGREEMENTAdoption Agreement • August 16th, 2017 • Yarkoni Shai • Surgical & medical instruments & apparatus
Contract Type FiledAugust 16th, 2017 Company IndustryThis Voting Agreement (this “Agreement”) made as of the 14th day of August, 2017, by and among Kasbian Nuriel Chirich of Simtat Ha-Irus 5, Rishpon, Israel ("Chirich") and Dr. Shai Yarkoni of Haviva Raig St 28A, Kfar Saba, Israel ("Shai"); Chirich and Shai shall collectively be referred to as the “Shareholders”).
AGREEMENTYarkoni Shai • August 16th, 2017 • Surgical & medical instruments & apparatus
Company FiledAugust 16th, 2017 IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of ordinary shares of Cellect Biotechnology Ltd.